Medicare’s final valuations were lower than specialty societies’ initial recommendations for 39.9% of physician services examined in a study published Sept. 1 in JAMA Network Open.
Here are five things to know:
- Researchers examined 2,173 Relative Value Scale Update Committee recommendations covering 1,934 unique CPT codes from 2004 to 2025, excluding 2011 and 2012.
- The RUC left 1,664 specialty society proposals unchanged, or 76.6%. Among its 509 adjustments, 482, or 94.7%, were devaluations.
- CMS left 1,436 RUC proposals unchanged, or 66.1%. Of its 737 adjustments, 488, or 66.2%, were devaluations and 249, or 33.8%, were upvaluations.
- From specialty societies’ initial proposals through CMS’ final valuations, 1,114 recommendations, or 51.3%, were unchanged; 846, or 39.9%, were devalued; and 213, or 9.8%, were upvalued.
- Devaluation rates varied by specialty. Anesthesiology had a devaluation rate of 83.3%, while neurosurgery had a rate of 77.8%.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
